ARTICLE | Financial News
Ascentage hops in Hong Kong IPO queue
August 31, 2018 6:20 PM UTC
Ascentage Pharma Group International (Suzhou, China) proposed Aug. 20 to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by BofA Merrill Lynch and Citi.
The biotech's pipeline comprises seven clinical candidates in testing to treat cancer, HBV and age-related diseases, and includes small molecules against protein-protein interactions in the apoptosis pathway and next generation tyrosine kinase inhibitors...
BCIQ Company Profiles